You are here

patents

AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq

Fierce Pharma

Wed, 05/26/21 - 12:05 pm

clinical trials

Crohn's Disease

atopic dermatitis

Will the COVID Vaccine Companies Fall off the Patent Cliff?

Motley Fool

Mon, 05/24/21 - 11:29 pm

Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict

Fierce Pharma

Wed, 05/19/21 - 11:05 pm

Pfizer calls proposed IP waiver for Covid vaccines a 'distraction' from finding real solutions on access

Endpoints

Wed, 05/12/21 - 11:43 pm

intellectual property

Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'

Fierce Pharma

Tue, 05/11/21 - 10:23 pm

U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech

Yahoo/Reuters

Sun, 05/9/21 - 11:01 pm

intellectual property

Pharma groups slam US decision to support COVID-19 vaccine patent waivers

RAPS.org

Thu, 05/6/21 - 11:14 pm

intellectual property

This Is Why Humira Isn't AbbVie's Biggest Problem Right Now

Motley Fool

Mon, 05/3/21 - 10:55 am

The continuing CRISPR patent saga

Endpoints

Thu, 04/8/21 - 10:27 am

Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies

Biopharma Reporter

Thu, 03/25/21 - 11:52 am

intellectual property

HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access

Stat

Thu, 03/25/21 - 11:16 am

Moderna Therapeutics

The top 10 drugs losing U.S. exclusivity in 2021

Fierce Pharma

Wed, 03/10/21 - 10:59 pm

Bayer unveils first look at its post-Xarelto, post-Eylea life—and it's better than expected

Fierce Pharma

Wed, 03/10/21 - 10:49 pm

Generics companies face risk as SCOTUS questions patent tribunal’s constitutionality

MedCity News

Fri, 03/5/21 - 10:24 am

AstraZeneca breathes sigh of relief as court blocks US Symbicort generic

Pharmaforum

Wed, 03/3/21 - 10:17 am

Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too

Endpoints

Fri, 02/12/21 - 10:48 am

What does Brexit mean for biopharma companies?

Biopharma Reporter

Tue, 02/9/21 - 01:06 pm

Which pharmaceutical drugs have the most patents?

Drug Patent Watch

Sun, 01/24/21 - 03:16 pm

Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead

Fierce Pharma

Tue, 01/19/21 - 09:18 pm

Gilead Sciences

Amarin vs. the Generics: Who Will Win?

Motley Fool

Sun, 11/22/20 - 11:55 pm

Pages